Literature DB >> 18938212

Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury.

Alma Sanchez1, Maurizo Chiriva-Internati, Paula Grammas.   

Abstract

Neurotrophic factors such as pituitary adenylate cyclase activating polypeptide (PACAP38) are promising therapeutics for neurodegenerative diseases. However, delivery of trophic factors into brain neurons remains a challenge. The objective of this study is to determine whether adeno-associated virus (AAV) can mediate PACAP38 gene delivery into neurons in vitro and if transduction of AAV/PACAP38 into cortical neurons protects cells against neurotoxic insult. Primary cortical neuronal cultures are transduced with rAAV/PACAP38/GFP and cell survival against the nitric oxide releasing neurotoxin sodium nitroprusside (SNP) determined. GFP expression, a surrogate marker for successful transduction, is detected using fluorescent microscopy. The results show expression of GFP transgene and AAV capsid proteins in neurons. PACAP38 transduction significantly increases cell survival of neurons exposed to SNP. These results support the feasibility of using AAV-mediated delivery of PACAP38 to enhance neuronal survival and suggest that AAV-delivered PACAP38 maybe a therapeutic strategy for neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938212      PMCID: PMC2640109          DOI: 10.1016/j.neulet.2008.10.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  42 in total

1.  Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells.

Authors:  H Hashimoto; N Hagihara; K Koga; K Yamamoto; N Shintani; S Tomimoto; W Mori; Y Koyama; T Matsuda; A Baba
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

2.  Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult.

Authors:  David Vaudry; Carol Hamelink; Ruslan Damadzic; Robert L Eskay; Bruno Gonzalez; Lee E Eiden
Journal:  Peptides       Date:  2005-07-11       Impact factor: 3.750

3.  Epidemiology of adenovirus-associated virus infection in a nursery population.

Authors:  N R Blacklow; M D Hoggan; A Z Kapikian; J B Austin; W P Rowe
Journal:  Am J Epidemiol       Date:  1968-11       Impact factor: 4.897

4.  Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.

Authors:  Ken-ichiro Fukuchi; Kazuki Tahara; Hong-Duck Kim; J Adam Maxwell; Terry L Lewis; Mary Ann Accavitti-Loper; Helen Kim; Selvarangan Ponnazhagan; Robert Lalonde
Journal:  Neurobiol Dis       Date:  2006-09       Impact factor: 5.996

5.  The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones.

Authors:  Victor Suarez; Orlando Guntinas-Lichius; Michael Streppel; Shota Ingorokva; Maria Grosheva; Wolfram F Neiss; Doychin N Angelov; Lars Klimaschewski
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

6.  Changes in expression of PACAP in rat sensory neurons in response to sciatic nerve compression.

Authors:  L M E Pettersson; L B Dahlin; N Danielsen
Journal:  Eur J Neurosci       Date:  2004-10       Impact factor: 3.386

Review 7.  Neurotrophins.

Authors:  Georg Dechant; Harald Neumann
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.

Authors:  G V Segre; S R Goldring
Journal:  Trends Endocrinol Metab       Date:  1993-12       Impact factor: 12.015

9.  Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats.

Authors:  Richa B Tripathi; Dana M McTigue
Journal:  J Comp Neurol       Date:  2008-09-10       Impact factor: 3.215

Review 10.  Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.

Authors:  Z Shevtsova; J M I Malik; U Michel; M Bähr; S Kügler
Journal:  Exp Physiol       Date:  2004-11-12       Impact factor: 2.969

View more
  6 in total

1.  Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2.

Authors:  A Sanchez; D Tripathy; X Yin; J Luo; J Martinez; P Grammas
Journal:  Neurosci Res       Date:  2011-09-17       Impact factor: 3.304

2.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Tibor Hajdú; Solveig Lind Helgadottir; János Fodor; László Csernoch; Gábor Tóth; Éva Bakó; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

Review 4.  Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death.

Authors:  Gabriella Horvath; Dora Reglodi; Eszter Fabian; Balazs Opper
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

5.  Effects of pituitary adenylate cyclase activating polypeptide on CD4(+)/CD8(+) T cell levels after traumatic brain injury in a rat model.

Authors:  Rong Hua; Shan-Shan Mao; Yong-Mei Zhang; Fu-Xing Chen; Zhong-Hai Zhou; Jun-Quan Liu
Journal:  World J Emerg Med       Date:  2012

6.  Pituitary adenylate cyclase activating polypeptide (PACAP) signalling exerts chondrogenesis promoting and protecting effects: implication of calcineurin as a downstream target.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Pál Gergely; László Csernoch; Gyorgy Panyi; Gábor Tóth; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.